FREE CME from Elsevier: Irritable Bowel Syndrome

New CME: Irritable Bowel Syndrome: Latest Advances in Pathophysiology, Diagnosis, and Patient Management Faculty Anthony J. Lembo, MD Ali Rezaie, MD, MSc, FRCP(C) Gerald W. Smetana, MD, MACP Inflammatory bowel syndrome (IBS) is the most common gastrointestinal disorder seen by primary care providers, yet it remains a source of frustration for both patients and physicians. Recent advances in our understanding of the etiology and pathophysiology of IBS have led to new diagnostic guidelines that avoid unnecessary testing so that IBS is no longer a diagnosis of exclusion. Treatment options are varied and evolving and include pharmacologic and non-pharmacologic options depending on the subtype of IBS and individual patient characteristics. This archived symposium will provide participants with the opportunity to assess new data and remaining challenges in the diagnosis and treatment of patients with IBS via interactive case scenarios. Upon successful completion of this activity you may receive up to 1.0 AMA PRA Category 1 Credit(s)™ Begin Free Online CME Activity You may also be interested in the following CME activity: Clinical Strategies & Scientific Advances in HEPATITIS C VIRUS (HCV)  1.25 AMA PRA Category 1 Credit™